🔎 Trials Near Me

Akèy › Kansè fwa (Kasinòm epatoselilè) › Alabama › Birmingham

Etid klinik pou Kansè fwa (Kasinòm epatoselilè) nan Birmingham, AL

8 etid pou Kansè fwa (Kasinòm epatoselilè) ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

Ap rekriteFaz 1/2
  • Research Facility, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06726161

A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • University of Alabama At Birmingham Hospital, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06427941

A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC

Ap rekriteFaz 1/2
  • University of Alabama at Birmingham, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT06294548

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Children's Hospital of Alabama, Birmingham
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Ap rekriteFaz 1
  • University of Alabama at Birmingham, Birmingham
  • University of Alabama at Birmingham, IDS Pharmacy, Birmingham
  • University of Alabama at Birmingham, Birmingham
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT05208762

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Ap rekrite
  • Birmingham VA Medical Center, Birmingham, AL, Birmingham
Laj 18 a 75 · Tout sèks · Mizajou Jun 17, 2026 · NCT05486572

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Ap rekriteFaz 1/2
  • The Kirklin Clinic of University of Alabama Birmingham Hospital, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Apr 27, 2026 · NCT05440708

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Birmingham
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè fwa (Kasinòm epatoselilè) nan lòt vil

Lòt etid nan Birmingham

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.